Alembic Pharmaceuticals Limited receives Establishment Inspection Report (EIR) for its Oncology Injectable Formulation Facility at Panelav.
US Food and Drug Administration (USFDA) for the inspection carried out by them at Alembic's Oncology Injectable Formulation Facility at Panelav during the period from 4th October, 2022 to 14th October, 2022.
source https://www.pharmatutor.org/content/december-2022/alembic-pharma-receives-eir-for-panelav-facility
No comments:
Post a Comment